-
Mashup Score: 29JACC | Priorities for Evidence Generation - 7 day(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 24NIH-FDA Nutrition Regulatory Science Workshop - 7 day(s) ago
The goal of this joint NIH-FDA workshop is to highlight how nutrition science can generate evidence and data to inform food-related policy and regulatory decision making and to foster additional collaboration between NIH and FDA in supporting research that addresses priority nutrition research gaps.
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet-
Diet related diseases are surging yet nutrition science needs to be improved. Thus @US_FDA and @NIH are collaborating for the first Nutrition Regulatory Science Workshop to devise the future of nutrition science and policy, focusing on ultraprocessed food. https://t.co/DrXtnXbPxv https://t.co/7mgEfNvxAK
-
-
Mashup Score: 29JACC | Priorities for Evidence Generation - 13 day(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 29JACC | Priorities for Evidence Generation - 13 day(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 2
This blog focuses on the potential of leveraging lifecycle management to address the unique challenges of generative AI in health care.
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet-
4/5 Since AI is a unique technology highly sensitive to context, it is essential to adopt a life cycle approach that incorporates recurrent evaluation of the technology in the setting it is being used in. We provide more details here: https://t.co/dtHHTs1H2Q https://t.co/ns0c0P8hmw
-
-
Mashup Score: 1Artificial Intelligence and Machine Learning for Drug Development - 2 month(s) ago
Computer science, statistics & engineering uses algorithms/models to perform tasks & exhibit behaviors such as learning, making decisions, and making prediction
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet-
3/5 Two areas where #AI has a lot of potential are clinical research and drug development. We provide examples of use cases in both domains. Readers can learn more about AI's role in drug development and research here: https://t.co/IHcA2ocMp8 https://t.co/aSGwiolDQN
-
-
Mashup Score: 1FDA and NIH Joint Public Meeting: Registration Open - 2 month(s) ago
On Monday, October 21, from 9 a.m. to 4:30 p.m. EDT, FDA and NIH will host a joint public meeting
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet-
The timing is perfect since next Monday, FDA and NIH are holding a joint *public meeting* on advancing smoking cessation. Registration is open - join us to help move this field forward together! Grateful to be part of this important mission. 3/3 https://t.co/LcZQZMzPLK
-
-
Mashup Score: 6
Smoking cessation is an important public health goal. Leaders from the National Institutes of Health (NIH) and U.S. Food and Drug Administration (FDA) provide an overview of the current regulatory …
Source: www.acpjournals.orgCategories: General Medicine News, CardiologistsTweet-
Helping people quit smoking is essential and @US_FDA and @NIH are working together to spur critically needed innovation for tobacco cessation. In @AnnalsofIM today, w/ @NIHDirector Dr Bertagnolli & @DrCaliff_FDA we outline our broad commitment. Link: https://t.co/ufOGdxCkZk 1/3 https://t.co/GVLpi8TPgR
-
-
Mashup Score: 16
A new study finds that almost half the counties in the United States lack a single cardiologist, a finding described as “truly shocking” by one researcher.
Source: www.washingtonpost.comCategories: General Medicine News, CardiologistsTweet-
🙏to @washingtonpost @pulitzercenter winner @majohnso for his feature w/ great interviews on a major crisis in cardiovascular health: 22 million Americans live in areas without cardiologists. Our leadership needs to step up. Need a transformative solution. https://t.co/aI8pylT1Sc https://t.co/mxnMM7TGU5
-
-
Mashup Score: 5Microplastics and Nanoplastics in Foods - 5 month(s) ago
Microplastics and nanoplastics may be present in food, primarily from environmental contamination where foods are grown or raised.
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet-
The health effects of microplastics have come under scrutiny recently. @US_FDA experts have long been studying and regulating their use - here is an updated page detailing their activities and efforts in this important area. CC @EricTopol https://t.co/85FIvxPeCD
-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb